Schroders Capital Global Innovation Trust plc – INOV (LON:INOV) Trading Up 2.9% – Still a Buy?

Posted by Renee Jackson on May 30th, 2026

Schroders Capital Global Innovation Trust plc – INOV (LON:INOV – Get Free Report) shares were up 2.9% during mid-day trading on Thursday . The stock traded as high as GBX 15.95 and last traded at GBX 15.75. Approximately 945,076 shares traded hands during mid-day trading, an increase of 33% from the average daily volume of 708,953 shares. The stock had previously closed at GBX 15.30.

Schroders Capital Global Innovation Trust plc – INOV Trading Down 0.3%

The stock has a market capitalization of £99.75 million, a PE ratio of 6.98 and a beta of 0.54. The firm’s fifty day moving average is GBX 14.92 and its 200-day moving average is GBX 14.80.

Schroders Capital Global Innovation Trust plc – INOV (LON:INOV – Get Free Report) last issued its quarterly earnings data on Thursday, April 2nd. The company reported GBX (0.24) earnings per share (EPS) for the quarter. The company had revenue of GBX 21 million for the quarter.

Insider Activity

In related news, insider Stephen Cohen acquired 120,000 shares of Schroders Capital Global Innovation Trust plc – INOV stock in a transaction that occurred on Tuesday, April 14th. The shares were purchased at an average cost of GBX 15 per share, for a total transaction of £18,000. Also, insider Jane Tufnell acquired 81,903 shares of Schroders Capital Global Innovation Trust plc – INOV stock in a transaction that occurred on Thursday, April 9th. The stock was bought at an average price of GBX 14 per share, for a total transaction of £11,466.42. 0.17% of the stock is currently owned by insiders.

Schroders Capital Global Innovation Trust plc – INOV Company Profile

(Get Free Report)

Schroder UK Public Private Trust plc specializes in investments in startups, midsize, middle market and large stage, early stage and mature stage investments. The fund primarily invests in the healthcare, financials, industrials, technology, consumer goods, telecommunications, basic materials, and biotechnology sector. It seeks to invest in quoted and unquoted companies. It primarily invests in companies incorporated in the United Kingdom or traded on a London Stock Exchange market but can invest in Europe, United States and Asia other countries.